主动脉内移植物取出的策略与结局
该研究基于前瞻性机构数据库,回顾2002至2017年32例因血管内动脉瘤修复(EVAR)失败行开放转换取出内移植物的患者,分析失败原因、手术策略及结局。结果显示完全与部分取出虽并发症率高但可安全实施,术后影像监测对髂动脉退变重要。
要点
- EVAR失败行开放转换取出内移植物,30天死亡率为6.3%,31%发生重大并发症。
- 破裂患者5年总生存率为33%,择期转换者为59%。
- 移除髂支者随访影像显示髂动脉退变(增长>5 mm)有增多趋势(29.4% vs 0%;P = .184)。
核心结论
- 完全与部分内移植物取出虽为高并发症手术,但可安全实施。
- 术后影像监测重要,尤其当内移植物已从髂动脉移除时,因可能发生退变。
研究设计与样本
- 前瞻性机构数据库回顾,纳入2002至2017年32例因EVAR失败行内移植物取出的患者。
- 分析人口学、失败原因、手术细节(含内移植物移除范围)及并发症/生存,并评估取出后CT影像的髂动脉退变。
主要发现
- 32例中6例因破裂急诊手术;平均年龄76 ± 8.5岁,白人100%,男性91%,EVAR植入至开放转换45.5个月(范围0.3-86个月),75%在外院植入。
- 失败原因为内漏91%(I型38%、II型28%、III型13%、V型13%),感染6%,闭塞/扭结3%;12例(37.5%)曾尝试血管内挽救。
- 手术入路经腹69%、腹膜后31%;初始主动脉阻断位置腹腔干上31%、肾上31%、肾下38%。
- 完全移除19例(59%),至少移除髂支22例(69%);肾上固定移植物更可能将上主体留在原位(67% vs 17%;P = .029)。
- 30天死亡率6.3%(择期3.8%,破裂16.7%),31%发生重大并发症;23例有随访影像者中,移除髂支者髂动脉退变(增长>5 mm)有增多趋势(29.4% vs 0%;P = .184)。
临床怎么用
- 完全与部分内移植物取出可安全实施,但为高并发症手术。
- 术后影像监测重要,尤其当内移植物已从髂动脉移除时。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Failure of endovascular aneurysm repairs (EVARs) requiring open conversion remains a major challenge. We analyzed indications for repair, operative strategies, and outcomes with a focus on iliac artery degeneration after endograft removal. METHODS: A prospective, institutional database was reviewed to identify patients who underwent explantation of a failed EVAR device. Demographics, reason for failure, operative details including extent of endograft removal, and complications/survival were examined. Postexplantation computed tomography imaging was evaluated for iliac artery degeneration. RESULTS: There were 32 patients who underwent explantation from 2002 to 2017. Six patients were treated emergently for rupture. The majority were elderly (average age, 76 ± 8.5 years), white (100%) men (91%) who had their EVAR graft inserted 45.5 months (range, 0.3-86 months) before open conversion, usually at an outside institution (75%). Explanted endografts included nine AneuRx (Medtronic, Minneapolis, Minn), nine Excluder (W. L. Gore & Associates, Flagstaff, Ariz), four Endurant (Medtronic), three Zenith (Cook Medical, Bloomington, Ind), three Powerlink/AFX (Endologix, Irvine, Calif), one Aorfix (Lombard Medical, Oxfordshire, United Kingdom), one Talent (Medtronic), and two unknown. Failure was due to endoleak in 91% (type I, 38%; type II, 28%; type III, 13%; type V, 13%), infection in 6%, and occlusion/kinking in 3%. A previous attempt at endovascular salvage of EVAR occurred in 12 (37.5%) patients. Operative approach was transabdominal in 69% and retroperitoneal in 31%. Initial aortic clamp position was supraceliac in 31%, suprarenal in 31%, and infrarenal in 38%. Most patients had complete removal of their endograft (n = 19 [59%]), with 22 (69%) having at least the iliac limbs removed. Grafts with suprarenal fixation were more likely to have the upper main body left in situ (67% vs 17%; P = .029). The 30-day mortality was 6.3% (3.8% elective, 16.7% ruptured), and 31% had a major complication. Of the 23 patients who had follow-up imaging, there was a trend for more iliac degeneration (>5 mm in growth) in those who had the iliac limbs removed (29.4% vs 0%; P = .184). Three patients with iliac limb removal required subsequent iliac endovascular intervention (two for rupture). Patients who presented with a rupture had a decreased 5-year overall survival (33%) compared with those who were converted electively (59%). CONCLUSIONS: Both complete and partial endograft explantation, although morbid procedures, can be performed safely. Postoperative imaging surveillance is important, especially if the endograft has been removed from the iliac arteries, as degeneration can occur.
引用
- Arnaoutakis DJ, Sharma G, Blackwood S, et al. Strategies and outcomes for aortic endograft explantation. J Vasc Surg. 2018. PMID: 29914836. doi:10.1016/j.jvs.2018.03.426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。